Qiu M, et al. suggested that microRNA-429 (miR-429), a modulator of epithelial-to-mesenchymal transition, plays a crucial role in tumorigenesis and tumor progression by direct targeting of E2F3 in renal cell carcinoma [31]. Here, E2F3 is linked to renal cell carcinoma.